Lyumjev Injection, Solution
Product Images NDC 50090-7433

Product Visual Gallery

This gallery contains 81 technical images submitted to the FDA as part of the official labeling for Lyumjev (NDC 50090-7433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907433)

LYUMJEV Insulin lispro-aabc Injection, Solution 100 Units per mL (U-100) multi-dose vial carton. The label highlights storage instructions, including refrigeration requirements and cautions against freezing or exposure to direct heat. The labeler is A-S Medication Solutions, Libertyville, Illinois.*

FDA Label Image

Figure (Logo)

FDA Label Image

Figure (Lyumjev Clock V1)

An illustration depicting a stopwatch showing a 5-second duration. The shaded segment on the stopwatch dial visually represents the 5-second time interval.*

FDA Label Image

Figure (Lyumjev Inj Sites V1)

Illustration showing recommended injection sites on a human body for LYUMJEV insulin lispro-aabc. Shaded areas highlight the abdomen, front and outer sides of the thighs, and the upper buttocks as potential injection locations for subcutaneous administration.*

FDA Label Image

Figure (Lyumjev Needle Tab V1)

An instructional illustration showing a hand twisting the cap off a vial or container, indicated by a red curved arrow suggesting the direction to turn the cap. The image likely guides on how to open the vial for use.*

FDA Label Image

Figure (Lyumjev Pen Attach Needle V1)

An instructional illustration showing a liquid solution being expelled from the tip of a syringe or pen device, indicated by a red arrow curving from the barrel to the nozzle. The image suggests priming or expelling air prior to injection.*

FDA Label Image

Figure (Lyumjev Pen Remove Needle V1)

Illustration showing a hand holding an insulin pen injector with an orange ribbon wrapped around the needle cover, depicting preparation or use instructions for insulin injection.*

FDA Label Image

Figure (Lyumjev Pen Remove Shield V1)

An instructional diagram showing the removal and disposal of a bottle cap. The image includes an arrow indicating to keep the cap and a direction to throw away a small internal component, illustrating proper preparation steps for using the LYUMJEV injection solution.*

FDA Label Image

Figure (Lyumjev Pen Replace Shield V1)

An instructional diagram showing a hand holding a syringe with its protective cap being pulled off, indicated by a red arrow pointing away from the syringe tip. This likely illustrates preparation steps for use of an injection.*

FDA Label Image

Figure (Lyumjev Pen Tap V1)

An instructional illustration depicting a hand holding a syringe and the other hand tapping the syringe barrel, likely to remove air bubbles or prepare the insulin lispro-aabc injection solution.*

FDA Label Image

Figure (Lyumjev Pen Uncap V1)

An instructional illustration showing a gray needle cap being removed from an injection pen or syringe by pulling it straight off to the left, indicated by a red leftward arrow.*

FDA Label Image

Qr Code (Lyumjev Qr V1)

FDA Label Image

Figure (Lyumjev U100 Jrkp Ifu F1 V1)

LYUMJEV Junior KwikPen injection, containing insulin lispro-aabc at 100 units per mL (U-100). The pen is designed for subcutaneous or intravenous use, intended for human prescription drug administration. It is labeled for single patient use and produced by A-S Medication Solutions.*

FDA Label Image

Figure (Lyumjev U100 Jrkp Ifu F10 V1)

An instructional illustration showing a person administering an injection by inserting a needle into the abdominal area, demonstrating the subcutaneous injection technique.*

FDA Label Image

Figure (Lyumjev U100 Jrkp Ifu F11 V1)

An illustration showing a syringe with a detachable cap clip. The diagram highlights the cap clip on the left side with an arrow pointing to the syringe, indicating removal or attachment of the cap clip.*

FDA Label Image

Figure (Lyumjev U100 Jrkp Ifu F2 V1)

Illustration diagram of LYUMJEV Junior KwikPen parts showing labeled components including the pen cap with cap clip, rubber seal, cartridge holder, plunger, pen body with label, dose window with dose indicator, and dose knob. The label displays LYUMJEV Junior KwikPen with insulin lispro-aabc injection details.*

FDA Label Image

Figure (Lyumjev U100 Jrkp Ifu F3 V1)

An instructional illustration showing parts of a pen needle including the outer needle shield, inner needle shield, needle, and paper tab. The diagram also depicts a dose knob, detailing components related to a medication pen device.*

FDA Label Image

Figure (Lyumjev U100 Jrkp Ifu F4 V1)

An instructional illustration showing a close-up view of a medication pen dose window. The dose window displays a numeric scale from 1 to 3, with a red arrow pointing upward toward the right side of the pen, indicating dose adjustment or injection direction.*

FDA Label Image

Figure (Lyumjev U100 Jrkp Ifu F5 V1)

An illustration showing a hand holding a syringe filled with liquid. The diagram highlights the needle cap being removed by pulling downward, depicted with a red arrow. The inset zooms in on the needle tip and cap for clarity. The image demonstrates proper preparation of an injection syringe.*

FDA Label Image

Figure (Lyumjev U100 Jrkp Ifu F6 V1)

An illustration showing a syringe barrel with volume markings visible, ranging from 0 to 0.5 mL. The syringe is partially filled, and the plunger is positioned on the right side. This diagram likely demonstrates measuring or dosing of an injectable solution.*

FDA Label Image

Figure (Lyumjev U100 Jrkp Ifu F7 V1)

An instructional illustration showing a close-up of a dosage window on a pen injector, with a red arrow pointing to the dose display area indicating the dose selection mechanism.*

FDA Label Image

Figure (Lyumjev U100 Jrkp Ifu F8 V1)

Close-up image of a LYUMJEV insulin lispro-aabc injection cartridge or pen with a visible dosage scale marked from 3 to 5 units. The device housing is gray with a beige or peach-colored cap. The product is an injection solution for intravenous or subcutaneous administration.*

FDA Label Image

Figure (Lyumjev U100 Jrkp Ifu F9 V1)

An instructional diagram showing a close-up view of an insulin pen cartridge with dose markings from 0 to 11 units. The image highlights the dosage scale on the cartridge, focusing on the precision of dose measurement for the insulin lispro-aabc injection solution.*

FDA Label Image

Figure (Lyumjev U100 Kp Ifu F1 V1)

LYUMJEV 100 units/mL injectable solution in a KwikPen delivery device. The pen shows dosing increment markings and a blue cap. Label indicates it is for single patient use only and for injection. The labeler is A-S Medication Solutions.*

FDA Label Image

Figure (Lyumjev U100 Kp Ifu F10 V1)

An instructional illustration showing a person pulling up their shirt to expose the abdomen and preparing to inject medication subcutaneously with a syringe or pen injector. The image depicts the injection site at the abdomen, demonstrating the proper technique for administering a subcutaneous injection.*

FDA Label Image

Figure (Lyumjev U100 Kp Ifu F11 V1)

An instructional diagram showing the removal of a cap clip from a syringe or injection pen. The cap clip is positioned to the left with a red arrow pointing right towards the syringe body, indicating the direction for cap clip removal.*

FDA Label Image

Figure (Lyumjev U100 Kp Ifu F2 V2)

Illustration of LYUMJEV KwikPen injection device parts showing the pen cap with cap clip, rubber seal, cartridge holder containing the plunger, pen body with label, dose indicator with dose window, and dose knob. The diagram labels each component for clear identification.*

FDA Label Image

Figure (Lyumjev U100 Kp Ifu F3 V1)

Illustration showing the parts of a pen needle, including the outer needle shield, inner needle shield, needle, and paper tab, with a note that needles are not included. Also shown is a separate dose knob component.*

FDA Label Image

Figure (Lyumjev U100 Kp Ifu F4 V1)

An instructional diagram showing a close-up of a syringe's dosage window with numbered measurement markings from 0 to 4. A red arrow points upward along the right side of the syringe barrel, likely indicating the direction to move or adjust the dosage setting for LYUMJEV insulin lispro-aabc injection.*

FDA Label Image

Figure (Lyumjev U100 Kp Ifu F5 V1)

An instructional illustration showing a hand holding a syringe filled with medication, demonstrating the process of expelling air or preparing the injection by pushing the plunger downward. A zoomed-in inset highlights the tip of the syringe with a drop of liquid.*

FDA Label Image

Figure (Lyumjev U100 Kp Ifu F6 V1)

An illustration showing a close-up view of a medication pen or injector device with a dose window displaying numbers. The image highlights the dosage selection or adjustment feature of the injection device.*

FDA Label Image

Figure (Lyumjev U100 Kp Ifu F7 V1)

An instructional diagram showing a hand gripping the end of a capped syringe or pen device with an arrow indicating the removal of the cap by pulling upward. The illustration focuses on the proper technique to uncapped the injection device for use.*

FDA Label Image

Figure (Lyumjev U100 Kp Ifu F8 V1)

An instructional diagram showing a close-up of a vial's label with a magnified view of a numerical value "12" highlighted by an arrow, presumably to indicate vial size or volume. The vial appears with a blue cap on top.*

FDA Label Image

Figure (Lyumjev U100 Kp Ifu F9 V1)

An illustration showing a magnified view of a syringe scale with numerical markings, highlighting the measurement around 24 to 26 units with a red arrow pointing to that area. The syringe is shown partially filled and the scale is used for dosing precision.*

FDA Label Image

Figure (Lyumjev U100 Tp Ifu F1 V1)

LYUMJEV Tempo Pen injection device is labeled for insulin lispro-aabc with a strength of 100 units per mL (U-100). The label specifies it is for single patient use only and requires a prescription. The pen has a gray body with a partially visible dosing scale and a removable blue cap.*

FDA Label Image

Figure (Lyumjev U100 Tp Ifu F10 V1)

Illustration showing the technique for subcutaneous injection of LYUMJEV (insulin lispro-aabc) injection solution. The image depicts a hand holding a syringe with an arrow indication direction, aiming toward the abdomen area, demonstrating proper administration method for the drug.*

FDA Label Image

Figure (Lyumjev U100 Tp Ifu F11 V1)

An instructional illustration showing how to remove a cap clip from a syringe. The image depicts a horizontal syringe with an attached cap clip on the left side and an arrow indicating the direction to slide or remove the cap clip off the syringe.*

FDA Label Image

Figure (Lyumjev U100 Tp Ifu F2 V1)

An illustration of LYUMJEV Tempo Pen parts, labeled from left to right, showing components including the pen cap with cap clip, rubber seal, cartridge holder, plunger, pen body with label, dose indicator, dose window, and dose knob.*

FDA Label Image

Figure (Lyumjev U100 Tp Ifu F3 V1)

An illustration showing parts of a pen needle, including the outer needle shield, inner needle shield, needle, and paper tab, with a note that needles are not included. Also depicted is a separate dose knob, likely a component of a medication delivery device.*

FDA Label Image

Figure (Lyumjev U100 Tp Ifu F4 V1)

An instructional illustration showing a close-up of a dosage measurement window with markings from 1 to 2 units and a blue adjustment dial. A red arrow points upward, indicating the direction to turn the dial, likely for setting dose amount on an injection device for LYUMJEV insulin lispro-aabc.*

FDA Label Image

Figure (Lyumjev U100 Tp Ifu F5 V1)

An instructional illustration showing a hand holding a prefilled syringe labeled LYUMJEV (insulin lispro-aabc) injection solution. The diagram highlights the tip of the syringe with a magnified view focusing on removing the protective cap from the needle. An upward arrow indicates the direction to pull off the cap.*

FDA Label Image

Figure (Lyumjev U100 Tp Ifu F6 V1)

An illustration of a close-up view of a drug delivery pen's dose selector window, showing a partial numerical display of the insulin units to be injected. The device includes a blue dial or knob on the right side for adjusting the dose. This is consistent with the device used for administering LYUMJEV insulin lispro-aabc injection, solution.*

FDA Label Image

Figure (Lyumjev U100 Tp Ifu F7 V1)

An instructional diagram showing a hand holding a vial or cartridge with a blue cap. An upward red arrow indicates the motion to pull or slide the blue cap off the vial, suggesting how to remove the cap prior to use.*

FDA Label Image

Figure (Lyumjev U100 Tp Ifu F8 V1)

An illustration showing a close-up view of a syringe or pen injector dose window, displaying dosing marks between 10 and 12 units with a red arrow pointing at the dosing indicator. The image highlights the dose selection area used for administering LYUMJEV insulin lispro-aabc injection.*

FDA Label Image

Figure (Lyumjev U100 Tp Ifu F9 V1)

An illustration showing a close-up view of a dosing window on an insulin pen with numbered dose increments visible, alongside a blue dial for adjusting the insulin dose. A red arrow points to the dose selection area, indicating precision in dosing.*

FDA Label Image

Figure (Lyumjev U100 Vial Ifu F1 V2)

The image shows a vial of LYUMJEV insulin lispro-aabc injection, 100 units per mL (U-100) strength. The vial is labeled for subcutaneous or intravenous use, contains 10 mL of solution, and features a protective cap with a rubber stopper underneath. The labeler is A-S Medication Solutions.*

FDA Label Image

Figure (Lyumjev U100 Vial Ifu F10 V1)

An instructional illustration showing a hand drawing liquid into a syringe from a vial. The inset shows a close-up of the syringe barrel with volume markings up to 40 units. An upward arrow indicates the direction of drawing the liquid into the syringe.*

FDA Label Image

Figure (Lyumjev U100 Vial Ifu F11 V1)

An instructional illustration showing a person drawing medication into a syringe from a vial. The image depicts hands holding the vial and syringe, with an arrow indicating the upward movement of the syringe plunger to withdraw the solution.*

FDA Label Image

Figure (Lyumjev U100 Vial Ifu F12 V1)

An instructional diagram showing human body front and back views with shaded areas indicating recommended injection sites for LYUMJEV (insulin lispro-aabc) injection, solution 100 IU/mL. Highlighted injection areas include the abdomen, front and outer thighs, and upper outer arms.*

FDA Label Image

Figure (Lyumjev U100 Vial Ifu F13 V1)

An instructional diagram showing a person administering an injection into the abdominal area. The illustration highlights the correct injection site and includes an arrow pointing to the location, demonstrating how to hold the syringe for subcutaneous injection.*

FDA Label Image

Figure (Lyumjev U100 Vial Ifu F14 V1)

An instructional illustration showing proper technique for subcutaneous injection in the torso area. It depicts one hand pinching the skin while the other hand inserts a syringe at an angle into the pinched tissue near the abdomen.*

FDA Label Image

Figure (Lyumjev U100 Vial Ifu F15 V1)

An instructional illustration showing a hand holding a syringe to inject medication subcutaneously into the abdominal area of a person. The diagram highlights proper injection technique with an arrow indicating the direction for syringe withdrawal.*

FDA Label Image

Figure (Lyumjev U100 Vial Ifu F2 V2)

An instructional diagram showing parts of a syringe including the needle shield, needle, plunger tip, syringe body, and plunger. The illustration highlights an example dose of 20 units indicated at the plunger tip on the syringe body graduations.*

FDA Label Image

Figure (Lyumjev U100 Vial Ifu F3 V1)

An instructional illustration showing a hand holding a vial and using the other hand to remove the vial's cap by pulling it upwards. The image demonstrates how to properly access the vial before drawing medication from it.*

FDA Label Image

Figure (Lyumjev U100 Vial Ifu F4 V1)

An instructional illustration showing a person holding a small vial with one hand and removing or placing a rubber stopper with the other hand, demonstrating preparation steps for an injection.*

FDA Label Image

Figure (Lyumjev U100 Vial Ifu F5 V1)

An instructional diagram showing hands holding a syringe and injecting into the skin. The syringe barrel is marked with measurement graduations from 10 to 40 units, and a downward arrow indicates the direction of injection.*

FDA Label Image

Figure (Lyumjev U100 Vial Ifu F6 V1)

An instructional illustration showing a person's hands using a syringe to draw medication from a vial. One hand holds the vial, while the other pulls back the syringe plunger to fill it with solution.*

FDA Label Image

Figure (Lyumjev U100 Vial Ifu F7 V1)

An instructional illustration showing two hands preparing an injection. One hand holds a vial while inserting a needle attached to a syringe into its rubber stopper. An arrow indicates the direction of needle insertion into the vial.*

FDA Label Image

Figure (Lyumjev U100 Vial Ifu F8 V1)

Illustration showing a hand holding a vial and a syringe being inserted into the vial for medication withdrawal. An inset image displays a syringe calibrated up to 40 units, indicating measurement markings used for precise dosing.*

FDA Label Image

Figure (Lyumjev U100 Vial Ifu F9 V1)

An instructional line drawing depicting two hands preparing a syringe and vial. One hand holds the vial upside down, while the other hand adjusts the syringe, illustrating the process of drawing medication into the syringe.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F1 V1)

LYUMJEV KwikPen injection pen containing insulin lispro-aabc at 200 units per mL (U-200) strength. The pen is designed for single patient use only and has a protective cap removed from one end, showing the dial for dosing. The label includes the brand and generic names with dosage instructions.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F10 V1)

The image shows a partial close-up of an insulin pen or injector device with visible dosing markings. The visible markings include a scale with increments including 10 and 15 units. The device is primarily gray with a darker gray dial or knob for dose adjustment. The product corresponds to LYUMJEV insulin lispro-aabc injection solution, 100 units/mL, labeled by A-S Medication Solutions.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F11 V1)

An instructional illustration showing a close-up of a hand pulling a tab or seal upwards, indicated by a red arrow pointing away from the tab. The image likely demonstrates how to open or prepare a component of the LYUMJEV injection solution packaging.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F12 V1)

An instructional diagram showing a close-up of an injection vial label with a red arrow pointing to a specific section, possibly illustrating where to read certain information on the vial label.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F13 V1)

An instructional diagram showing a close-up view of dosage markings on a measurement device, with a red arrow pointing to the 24-26 unit range. This likely relates to dosage measurement for an injectable solution.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F14 V1)

An instructional illustration showing a person administering an injection into the abdominal area. The person uses one hand to pinch the skin and the other hand to insert the syringe needle at the injection site, indicating a subcutaneous injection technique.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F15 V1)

The image shows a partial view of a syringe barrel containing LYUMJEV (insulin lispro-aabc) injection, solution at a strength of 100 units/mL. The syringe displays graduated markings for dosing measurement. The labeler is A-S Medication Solutions.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F16 V1)

An illustration showing a hand holding a prefilled insulin injection pen, with the cap being removed by pulling it away from the pen. The pen features a visible yellow warning label on its body.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F17 V1)

An illustration showing a hand holding a syringe with a red cap or shield partially removed, revealing a yellow label on the syringe barrel. The image depicts a step in the preparation or handling of an injection device, likely for administering a drug such as LYUMJEV (insulin lispro-aabc) injection solution.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F18 V1)

Illustration shows an insulin pen injector with the cap removed and a labeled cartridge visible inside, highlighting the cap clip and direction to remove the cap. This diagram appears related to the assembly or preparation process for an injection device.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F2 V1)

A yellow warning label with black text stating: 'DO NOT TRANSFER TO A SYRINGE SEVERE OVERDOSE CAN RESULT,' including a black exclamation mark in a triangle alert symbol on the left side.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F3 V1)

Illustration showing components of the LYUMJEV KwikPen injection device, including the pen cap, cartridge holder with label, plunger, pen body, dose window, dose indicator, and dose knob. Also depicts parts of the pen needle (not included), such as outer needle shield, inner needle shield, needle, and paper tab, along with a standalone image of the dose knob.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F4 V1)

An instructional illustration showing the removal of a protective cap from a syringe or injection pen. A gray cap is positioned next to the injection device with a red arrow pointing left, indicating the direction to pull the cap off before use.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F5 V1)

An instructional illustration showing an arrow indicating the removal of a cap from the tip of a syringe or vial. The image guides the user to peel away the protective cap by pulling it upward and away from the device.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F6 V1)

An instructional diagram showing proper disposal of an injection cap. The image indicates to keep the wider open injection cap with an arrow pointing left, and to throw away the needle with a protective cover pointing right, illustrated by corresponding arrows and text.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F7 V1)

An instructional illustration showing a close-up view of the dose window on an injection pen device. The dose setting displays dose units, indicating where the user can adjust the injection amount by turning or pressing a mechanism, guided by an upward red arrow for dose selection.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F8 V1)

An instructional illustration showing a hand holding a syringe labeled LYUMJEV (Insulin lispro-aabc) 100 units/mL. The hand is tapping or flicking the syringe, suggesting preparation before injection.*

FDA Label Image

Figure (Lyumjev U200 Kp Ifu F9 V1)

An instructional illustration showing hands holding and preparing a syringe with a vial. A magnified circular inset details the syringe needle tip and vial puncture, while a red arrow indicates the direction for pressing or inserting the syringe into the vial.*

FDA Label Image

Primary Structure (Lyumjev Uspi Chem V1)

Chemical structure diagram of insulin lispro-aabc, showing the sequence and arrangement of amino acids in the A-chain and B-chain with their respective residues and disulfide bonds indicated.*

FDA Label Image

Figure 1 (Lyumjev Uspi F1 V1)

A line graph depicting the insulin effect (GIR: mg/kg/min) over time (hours) for LYUMJEV injection solution at three dose levels: 30 units, 15 units, and 7 units. The graph shows the change in insulin effect from 0 to 7 hours, with separate lines for each dose indicating their respective response curves.*

FDA Label Image

Figure 2 (Lyumjev Uspi F2 V1)

A line chart depicting the mean serum insulin lispro concentration (pmol/L) over time (hours) following administration of LYUMJEV. The graph shows concentration rising sharply to a peak around 1 hour, then gradually declining to near baseline by 5 hours, with time on the x-axis and concentration on the y-axis.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.